Marketing-authorisation holder · United States
Rk Pharma
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARBAMAZEPINE100mg | 200mg | 300mg | 400mg · Tablet | Carbamazepine | United States | Marketed | 1986 |
| DOFETILIDE0.125mg | 0.25mg | 0.5mg · Capsule | Dofetilide | United States | Marketed | 2016 |
| MYCOPHENOLATE SODIUM180mg base | 360mg base · Tablet, delayed release | Mycophenolate mofetil | United States | Marketed | 2014 |
| SELEXIPAG0.2mg | 0.4mg | 0.6mg | 0.8mg | 1.2mg | 1.4mg | 1.6mg | 1mg · Tablet | Selexipag | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.